2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
41
Terminated
21
Recruiting
12
Unknown
9
Active not recruiting
9
Withdrawn
5
Suspended
1
Not yet recruiting
1
Sponsor Class
NETWORK
1
Study Type
Interventional
1
Sponsor
Conditions
Respiratory Distress Syndrome
1
Pneumonia, Viral
1
Cytokine Release Syndrome
1
Interventions
Specimen Handling
31
Magnetic Resonance Spectroscopy
19
Biopsy
16
Cyclophosphamide
15
Nivolumab
10
Paclitaxel
9
Vincristine
8
Cisplatin
8
venetoclax
7
Prednisone
7
Gemcitabine
7
Doxorubicin
7
Bevacizumab
7
Azacitidine
7
pembrolizumab
6
Radiotherapy
6
Fluorouracil
6
Etoposide
6
Drug Therapy
6
Docetaxel
6
Surgical Procedures, Operative
5
Rituximab
5
Radiosurgery
5
Oxaliplatin
5
Irinotecan
5
Injections
5
Everolimus
5
Capecitabine
5
fludarabine phosphate
4
Taxes
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Suspended
×
Hydroxychloroquine
×
Clear all
NCT04394182
2022-03-29
ULTRA-COVID
Fundacion GenesisCare
Phase NA
Suspended
15 enrolled